Compare HCWB & OPTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HCWB | OPTH |
|---|---|---|
| Founded | 2018 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.8M | 15.5M |
| IPO Year | 2021 | N/A |
| Metric | HCWB | OPTH |
|---|---|---|
| Price | $3.30 | $4.75 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $35.00 | N/A |
| AVG Volume (30 Days) | ★ 459.2K | 103.6K |
| Earning Date | 05-15-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.37 | N/A |
| Revenue | ★ $4,099,750.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $10.35 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.25 | $4.00 |
| 52 Week High | $7.35 | $5.45 |
| Indicator | HCWB | OPTH |
|---|---|---|
| Relative Strength Index (RSI) | 51.53 | 56.45 |
| Support Level | $0.37 | $4.47 |
| Resistance Level | $3.89 | $5.33 |
| Average True Range (ATR) | 0.39 | 0.38 |
| MACD | -0.13 | 0.01 |
| Stochastic Oscillator | 8.94 | 44.44 |
HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.